Cytos Biotechnology AG - Novel technologies for functional genomics and antibody mediated therapies

Citation
C. Blaser et al., Cytos Biotechnology AG - Novel technologies for functional genomics and antibody mediated therapies, CHIMIA, 54(4), 2000, pp. 165-168
Citations number
7
Categorie Soggetti
Chemistry
Journal title
CHIMIA
ISSN journal
00094293 → ACNP
Volume
54
Issue
4
Year of publication
2000
Pages
165 - 168
Database
ISI
SICI code
0009-4293(2000)54:4<165:CBA-NT>2.0.ZU;2-5
Abstract
The overall goal of Cytos is the creation of new technologies and products for broad markets by breakthrough innovations in the biomedical sciences. B y adding eukaryotic viruses to the toolbox of modern biotechnology, Cytos h as developed unprecedented and broadly applicable platform technologies for drug discovery and development. Our technologies enable and facilitate the discovery, manufacture, delivery, and display of proteins.